You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Waldenstrom Macroglobulinemia

Showing 1 - 25 of 407
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)

Recruiting
  • Waldenstrom Macroglobulinemia
  • DASATINIB
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 22, 2022

Questionnaire and Tissue Banking For Multiple Myeloma,

Active, not recruiting
  • Multiple Myeloma
  • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 15, 2022

    Waldenstrom Macroglobulinemia Trial (Venetoclax; Rituximab, DRC)

    Not yet recruiting
    • Waldenstrom Macroglobulinemia
    • Venetoclax; Rituximab
    • DRC
    • (no location specified)
    Jul 27, 2022

    Waldenstrom's Macroglobulinemia Trial in Boston (Ulocuplumab, Ibrutinib)

    Active, not recruiting
    • Waldenstrom's Macroglobulinemia
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jun 20, 2022

    Waldenstrom Macroglobulinemia, Waldenstrom's Disease, Waldenström; Hypergammaglobulinemia Trial in New York (Ibrutinib,

    Recruiting
    • Waldenstrom Macroglobulinemia
    • +6 more
    • New York, New York
      Weill Cornell Medicine
    Dec 21, 2021

    Zanubrutinib in Waldenström's Macroglobulinemia (ARIADNE)

    Recruiting
    • Waldenström's Macroglobulinemia
    • Salzburg, Austria
    • +1 more
    May 2, 2022

    Waldenström's Macroglobulinemia Trial in Busan (Lenalidomide, Bortezomib, Rituximab, Dexamethasone)

    Recruiting
    • Waldenström's Macroglobulinemia
    • Lenalidomide, Bortezomib, Rituximab, Dexamethasone
    • Busan, Sue-gu, Korea, Republic of
      Kosin University Gospel Hospital
    Mar 31, 2022

    Waldenstrom Macroglobulinemia Trial in Boston (Loncastuximab Tesirine, Dexamethasone)

    Recruiting
    • Waldenstrom Macroglobulinemia
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 1, 2022

    Waldenstrom's Macroglobulinemia Trial in Boston (Ibrutinib)

    Active, not recruiting
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Boston, Massachusetts
    • +1 more
    Dec 15, 2021

    Waldenstrom Macroglobulinemia, MYD88 Gene Mutation Trial in Boston (IBRUTINIB, Venetoclax)

    Active, not recruiting
    • Waldenstrom Macroglobulinemia
    • MYD88 Gene Mutation
    • Boston, Massachusetts
    • +1 more
    Apr 1, 2022

    Waldenström Macroglobulinemia Trial in Vandoeuvre les Nancy (Blood or bone marrow samples)

    Completed
    • Waldenström Macroglobulinemia
    • Blood or bone marrow samples
    • Vandoeuvre les Nancy, France
      CHRU Nancy
    Aug 1, 2021

    Waldenstrom Macroglobulinemia Trial in New York (Epratuzumab (hLL2- anti-CD22 humanized antibody))

    Terminated
    • Waldenstrom Macroglobulinemia
    • Epratuzumab (hLL2- anti-CD22 humanized antibody)
    • New York, New York
    • +1 more
    Aug 12, 2021

    Cancer Prevention, Weight Loss, Smoldering Waldenstrom Macroglobulinemia(WM) Trial in Boston (Prolonged Fasting Intervention,

    Not yet recruiting
    • Cancer Prevention
    • +5 more
    • Prolonged Fasting Intervention
    • EDUCATION CONTROL
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Oct 3, 2022

    Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (WM) Trial in Rochester (Shingrix vaccine)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Waldenstrom Macroglobulinemia (WM)
    • Shingrix vaccine
    • Rochester, New York
      University of Rochester
    Feb 7, 2022

    Waldenstrom Macroglobulinemia Trial in Canada (Acalabrutinib, Bendamustine, Rituximab)

    Recruiting
    • Waldenstrom Macroglobulinemia
    • Vancouver, British Columbia, Canada
    • +3 more
    Jul 23, 2021

    Hyperviscosity Syndrome, Waldenstrom Macroglobulinemia Trial in Amiens (other, biological, procedure)

    Recruiting
    • Hyperviscosity Syndrome
    • Waldenstrom Macroglobulinemia
    • fundoscopic picture
    • +2 more
    • Amiens, France
      CHU Amiens
    May 19, 2021

    Covid-19 Vaccine Responsiveness in MM and Waldenstrom

    Not yet recruiting
    • Multiple Myeloma
    • +3 more
      • Boston, Massachusetts
      • +1 more
      Mar 31, 2021

      Relapsed/Refractory Waldenstrom Macroglobulinemia, Relapsed/Refractory Richter Transformation, Relapsed/Refractory Burkitt

      Not yet recruiting
      • Relapsed/Refractory Waldenstrom Macroglobulinemia
      • +3 more
      • Brexucabtagene Autoleucel
      • +2 more
      • (no location specified)
      Sep 8, 2022

      Waldenstrom's Macroglobulinemia Trial in Denver, Boston (LBH589)

      Completed
      Has Results
      • Waldenstrom's Macroglobulinemia
      • Denver, Colorado
      • +1 more
      Jan 10, 2021

      Waldenstrom's Disease, Waldenstrom Macroglobulinemia Trial in Amiens (bone marrow sample, blood sample)

      Recruiting
      • Waldenstrom's Disease
      • Waldenstrom Macroglobulinemia
      • bone marrow sample
      • blood sample
      • Amiens, France
        CHU Amiens
      May 17, 2021

      Waldenström's Macroglobulinemia (WM) Trial in China (Zanubrutinib)

      Completed
      Has Results
      • Waldenström's Macroglobulinemia (WM)
      • Beijing, Beijing, China
      • +10 more
      Mar 7, 2022

      Waldenstrom's Macroglobulinemia Trial in Boston (Everolimus, Rituximab, Bortezomib)

      Terminated
      Has Results
      • Waldenstrom's Macroglobulinemia
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Apr 22, 2021

      Waldenstrom Macroglobulinemia Trial in Austria, Germany, Greece (Carfilzomib + Ibrutinib, Ibrutinib)

      Recruiting
      • Waldenstrom Macroglobulinemia
      • Salzburg, Austria
      • +16 more
      Mar 11, 2022

      IgM MGUS, Waldenstrom Macroglobulinemia, Neuropathy;Peripheral Trial in Boston (Acalabrutinib, Rituximab)

      Recruiting
      • IgM MGUS
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Feb 16, 2022

      IgA Monoclonal Gammopathy, IgG Monoclonal Gammopathy, IgM Monoclonal Gammopathy Trial in Atlanta (Rifaximin)

      Recruiting
      • IgA Monoclonal Gammopathy
      • +8 more
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Oct 18, 2021